Last $5.88 USD
Change Today +0.12 / 2.08%
Volume 4.6M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph P. Hagan

Acting Chief Financial Officer, Principal Accounting Officer, Chief Business Officer and Treasurer, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 6 different industries.

See Board Relationships
45$1,920,782
As of Fiscal Year 2013

Background*

Mr. Joseph P. Hagan, also known as Jay, serves as the Chief Business Officer, Principal Accounting Officer and Treasurer at Orexigen Therapeutics, Inc. and has been its Acting Chief Financial Officer since March 2011. Mr. Hagan served as Senior Vice President of Corporate Development, Strategy, Communications & Technical Operations at Orexigen Therapeutics since May 2009. He is the Founder of Access Bioventures. He served as the President and Managing Director at Amgen ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

Member of Board of Directors
Director
Former Director
Former Director
Former Director
Former Director

Education*

Master's Degree
Northeastern University
MBA
Northeastern University
BS
University of California - San Diego

Other Affiliations*

Annual Compensation*

Salary$370,000
Total Annual Compensation$370,000

Stock Options*

All Other Compensation$7,770
Exercised Options50,000
Exercised Options Value$280,600
Exercisable Options619,454
Unexercisable Options804,546
Total Value of Options$280,600
Total Number of Options1,474,000

Total Compensation*

Total Annual Cash Compensation$592,370
Total Short Term Compensation$370,000
Other Long Term Compensation$7,770
Total Calculated Compensation$1,920,782
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $5.88 USD +0.12

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.